SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001165527-19-000089
Filing Date
2019-05-20
Accepted
2019-05-20 17:04:41
Documents
47
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 g8702.htm 10-Q 649647
2 ex10-39a.htm EX-10.39A 182223
3 ex31.htm EX-31 14999
4 ex32.htm EX-32 5049
11 schedule.jpg GRAPHIC 25790
  Complete submission text file 0001165527-19-000089.txt   2534389

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clcs-20190331.xml EX-101.INS 274882
6 XBRL TAXONOMY EXTENSION SCHEMA clcs-20190331.xsd EX-101.SCH 38563
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20190331_cal.xml EX-101.CAL 36914
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20190331_def.xml EX-101.DEF 117553
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20190331_lab.xml EX-101.LAB 195910
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20190331_pre.xml EX-101.PRE 156930
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 19839601
SIC: 2834 Pharmaceutical Preparations